Your browser doesn't support javascript.
loading
Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis.
Engel, Sinah; Protopapa, Maria; Steffen, Falk; Papanastasiou, Vakis; Nicolaou, Christoforos; Protopapas, Michalis; Zipp, Frauke; Bittner, Stefan; Luessi, Felix.
Afiliación
  • Engel S; Department of Neurology, Focus Program Translational Neuroscience (FTN), and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Protopapa M; Department of Neurology, Focus Program Translational Neuroscience (FTN), and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Steffen F; Department of Neurology, Focus Program Translational Neuroscience (FTN), and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Papanastasiou V; Aretaeio Hospital, 55-57 Andrea Avraamides, Strovolos, 2024 Nicosia, Cyprus.
  • Nicolaou C; Aretaeio Hospital, 55-57 Andrea Avraamides, Strovolos, 2024 Nicosia, Cyprus.
  • Protopapas M; Aretaeio Hospital, 55-57 Andrea Avraamides, Strovolos, 2024 Nicosia, Cyprus.
  • Zipp F; Department of Neurology, Focus Program Translational Neuroscience (FTN), and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Bittner S; Department of Neurology, Focus Program Translational Neuroscience (FTN), and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Luessi F; Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstrasse 1, Mainz 55131, Germany.
Ther Adv Neurol Disord ; 14: 17562864211001977, 2021.
Article en En | MEDLINE | ID: mdl-33959194
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Neurol Disord Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Neurol Disord Año: 2021 Tipo del documento: Article País de afiliación: Alemania